MPD: List measures where strain C57BL/10J is an outlier

List measures where C57BL/10J is an outlier

Click on pulldowns below to see C57BL/10J means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Bodnar1:28	Bodnar1	intake monitoring	sucrose	percent sucrose calories to daily total caloric intake with sucrose in drinking water [%] pct_suc_cal 22628 baseline 0.01% 2.5% 20%	inbred	11	m	13-17wks	N=10	2006

Chang1:20	Chang1	colony observation	(none)	animal age at test (local parameter) [wks] age 15720	inbred	17	both		N=15	2008

Everett1:12	Everett1	bone dimensions	(none)	mandible, diastema to pogonion [mm] incisor_region 11012	inbred	14	both	8-9wks	N=10	2003

Evsikova1:16	Evsikova1	monitoring system	(none)	ambulatory activity (beam break triplets during 24h) [n] horiz 24716 daily light dark	inbred	14	both	26wks	N=7	2009

Hawes1:17	Hawes1	slit lamp	(none)	suture cataract [frequency rate] cat_suture 26717	inbred w/CC7	40	both	6-7wks	N=10	2008

Korstanje1:11	Korstanje1	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 29711 12mo 18mo 24mo	inbred	30	both		N=7	2008

Mills1:31	Mills1	chromosome instability assessment	(none)	red blood cells (RBC) with micronuclei [%] RBC_micronucl 25231 6mo 12mo 20mo	inbred	30	both		N=5	2008

Mills1:35	Mills1	chromosome instability assessment	(none)	non-nucleated peripheral blood cells with micronuclei [%] all_micronucl 25235 6mo 12mo 20mo	inbred	30	both		N=5	2008

Naggert1:2	Naggert1	metabolic panel	high-fat diet	glucose (plasma GLU, 4h fast) [mg/dL] GLU 14302 baseline after 17wks on diet Δchange	inbred w/CC7	43	both	7-9wks	N=10	2003

Paigen1:9	Paigen1	histopathology	high-fat diet	gallbladder, mucin (score: 0-4) [score] mucin 2909	inbred	43	both	15-19wks	N=8	2000

Paigen1:14	Paigen1	histopathology	high-fat diet	gallbladder, fused liquid crystals (score: 0-4) [score] fusedLC 2914	inbred	43	both	15-19wks	N=8	2000

Paigen1:16	Paigen1	histopathology	high-fat diet	gallbladder, number of sandy stones [n] sandysto 2916	inbred	43	both	15-19wks	N=8	2000

Paigen1:17	Paigen1	histopathology	high-fat diet	gallbladder, number of true gallstones [n] gs 2917	inbred	43	both	15-19wks	N=8	2000

Paigen1:18	Paigen1	histopathology	high-fat diet	gallbladder, number of sandy plus true stones [n] nstones 2918	inbred	43	both	15-19wks	N=8	2000

Paigen4:1	Paigen4	lipid profile	(none)	HDL cholesterol (plasma) [mg/dL] HDLC 19701	inbred w/CC7	43	both	10wks	N=12	2002

Peters4:13	Peters4	complete blood count	(none)	lymphocyte count (LYM; units per volume x 10³) [n/µL] LYMPH 24313 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:17	Peters4	complete blood count	(none)	monocyte count (MONO; units per volume x 10³) [n/µL] MONO 24317 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:25	Peters4	complete blood count	(none)	basophil count (BASO; units per volume x 10³) [n/µL] BASO 24325 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:65	Peters4	complete blood count	(none)	mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 24365 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:77	Peters4	complete blood count	(none)	reticulocyte count (Retic) [n/L] Retic 24377 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:85	Peters4	complete blood count	(none)	reticulocyte corpuscular hemoglobin (CHr) [pg] CHr 24385 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:93	Peters4	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] Plt 24393 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:21	Petkova1	immune cell quantification	(none)	monocyte differential (MONO; percentage of total WBC) [%] MONO 24221 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:25	Petkova1	immune cell quantification	(none)	B cells, as percentage of total lymphocytes [%] B_cells 24225 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:66	Petkova1	immune cell quantification	(none)	CD8 T cells, effector memory, as percentage of total CD8 T cells [%] CD8_mem_effector 24266 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:76	Petkova1	immune cell quantification	(none)	natural killer (NK) cells, as percentage of total lymphocytes [%] NK 24276 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Project1032:1	Project1032	operant conditioning chamber	(none)	number of infusions earned (intravenous self administration), saline [n] infusions_control 111414 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:21	Project1032	operant conditioning chamber	(none)	number of infusions earned (intravenous self administration) combined, saline [n] infusions_combined_control 111434 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=2	2020

Project1032:53	Project1032	operant conditioning chamber	(none)	number of active lever presses (during infusions and timeouts) (intravenous self administration), saline [n] active_control 111466 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:73	Project1032	operant conditioning chamber	(none)	number of active lever presses (during infusions and timeouts) (intravenous self administration) combined, saline [n] active_combined_control 111486 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=2	2020

Project1032:79	Project1032	operant conditioning chamber	(none)	number of inactive lever presses (intravenous self administration), saline [n] inactive_control 111492 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:105	Project1032	operant conditioning chamber	(none)	session duration (120 min max) (intravenous self administration), saline [min] session_time_control 111518 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=3	2020

Project1032:125	Project1032	operant conditioning chamber	(none)	session duration (120 min max) (intravenous self administration) combined, saline [min] session_time_combined_control 111538 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=3	2020

Rusyn5:3	Rusyn5	metabolite quantification	high-fat diet and ethanol	homocysteine concentration (plasma) [nmol/mL] plasma_homocysteine 43003 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:23	Rusyn5	metabolite quantification	high-fat diet and ethanol	reduced liver glutathione (GSH) [nmol/mg] liver_GSH 43023 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:29	Rusyn5	metabolite quantification	high-fat diet and ethanol	ratio of reduced to oxidized liver glutathione [ratio] liver_GSHratio 43029 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Threadgill1:83	Threadgill1	biomarker quantification	acetaminophen	cytochrome P450 1A2 isoform [pmol/mg] CYP1A2 19483 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:76	Yuan3	metabolic panel	(none)	thyroxine (serum T4) [µg/dL] T4 24476 6mo 12mo 18mo	inbred	32	both		N=7	2008

List measures where C57BL/10J is an outlier

Filter Table Results